Parallel Advisors »

Travere Therapeutics shares owned by Parallel Advisors

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.6k 287 8.99
2022-09-30 $999 41 24.39
2022-06-30 $0 4 0.00

More positions owned by Parallel Advisors

Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Ishares S&p 500 Index Etf (IVV)
Apple Stock (AAPL)
Corcept Therapeutics Stock (CORT)
Ishares Msci Usa Quality Factor Etf Etf (QUAL)
Microsoft Stock (MSFT)
Cvb Finl Corp Stock (CVBF)
Nvidia Corp Stock (NVDA)
Ishares Core Msci Eafe Etf Etf (IEFA)
Vanguard Large Cap Etf (VV)
Amazon.com Stock (AMZN)
Ishares Tr Lehman Short Trea Bd Etf (SHV)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Ishares Aggregate Bond Etf Etf (AGG)
Vanguard Small Cap Etf Etf (VB)

View all positions for Parallel Advisors

Top funds holding Travere Therapeutics

Vanguard Group
Deutsche Bank Aktiengesellschaft
Kynam Capital Management
Jacobs Levy Equity Management
D. E. Shaw & Co
Bank of America Corporation
Goldman Sachs Group
Millennium Management
Emerald Advisers
Avidity Partners Management
Emerald Mutual Fund Advisers, Trust
Schonfeld Strategic Advisors
Barclays
Healthcare Of Ontario Pension Plan Trust Fund
Two Sigma Advisers

View all funds holding Travere Therapeutics